Literature DB >> 27765464

Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease.

T B Opstad1, B S Brusletto2, H Arnesen3, A Å Pettersen4, I Seljeflot3.   

Abstract

RATIONALE: The heterodimer IL-12 is an inducer of Th1 responses and stimulates INFƴ production. Micro-RNA-21 (miR-21) is described as a key regulator of the pro-inflammatory response and has IL-12p35 mRNA as one of its main targets. The IL-12p40 1188A/C genetic variant located in 3'untranslated region (UTR), thus environmentally exposed, has further been reported to modify IL-12 levels. We have previously reported on the lowering effect of cigarette smoke on circulating IL-12 in patients with coronary artery disease (CAD).
OBJECTIVES: To explore if cigarette smoking affects IL-12p35, IL-12p40, INFƴ and miR-21 gene-expression and further modulates any effect of the IL-12p40 polymorphism on circulating IL-12 levels. METHODS AND
RESULTS: The IL-12p40 1188A/C polymorphism was analyzed in 1001 stable CAD patients, of which 330 subjects were included for IL-12p35, IL-12p40 and INFƴ gene-expression analyses in circulating leukocytes and 200 were further selected for plasma miR-21 analysis. Smoking associated with lower expression of miR-21 and its target IL-12p35 mRNA (adjusted p<0.05, both) whereas the influence on INFƴ expression tended to be high-dose reliant (p = 0.057). The IL-12p40 CC genotype associated with elevated circulating IL-12 levels, however, when stratified according to smoking, only in the non-smoking group (adjusted p < 0.05). Although the markers were mainly downregulated in current smokers, their inter-correlations were potentiated.
CONCLUSION: Smoking associated with reduced miR-21 gene-repression and the results can therefore not explain the previously observed reduction in circulating IL-12. Smoking attenuated the IL-12 pro-inflammatory axis in which the investigated IL-12p40 genetic variant may have different clinical impact in smokers vs non-smokers.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cigarette smoking; Gene-expression; Genetic polymorphism; IL-12; INFƴ; MiR-21

Mesh:

Substances:

Year:  2016        PMID: 27765464     DOI: 10.1016/j.imbio.2016.10.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  4 in total

1.  Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease.

Authors:  Arno R Bourgonje; Laura A Bolte; Lianne L C Vranckx; Lieke M Spekhorst; Ranko Gacesa; Shixian Hu; Hendrik M van Dullemen; Marijn C Visschedijk; Eleonora A M Festen; Janneke N Samsom; Gerard Dijkstra; Rinse K Weersma; Marjo J E Campmans-Kuijpers
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

2.  Physiological response and microRNA expression profiles in head kidney of genetically improved farmed tilapia (GIFT, Oreochromis niloticus) exposed to acute cold stress.

Authors:  Jun Qiang; Yan T Cui; Fan Y Tao; Wen J Bao; Jie He; Xia H Li; Pao Xu; Lan Y Sun
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

3.  Adolescent Ethanol Exposure Leads to Stimulus-Specific Changes in Cytokine Reactivity and Hypothalamic-Pituitary-Adrenal Axis Sensitivity in Adulthood.

Authors:  Andrew S Vore; Tamara Doremus-Fitzwater; Anny Gano; Terrence Deak
Journal:  Front Behav Neurosci       Date:  2017-05-04       Impact factor: 3.558

4.  The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.

Authors:  Arno R Bourgonje; Shixian Hu; Lieke M Spekhorst; Daria V Zhernakova; Arnau Vich Vila; Yanni Li; Michiel D Voskuil; Lisette A van Berkel; Brenda Bley Folly; Mohammed Charrout; Ahmed Mahfouz; Marcel J T Reinders; Julia I P van Heck; Leo A B Joosten; Marijn C Visschedijk; Hendrik M van Dullemen; Klaas Nico Faber; Janneke N Samsom; Eleonora A M Festen; Gerard Dijkstra; Rinse K Weersma
Journal:  J Crohns Colitis       Date:  2022-03-14       Impact factor: 9.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.